Morgan Stanley raised the firm’s price target on Incyte (INCY) to $102 from $94 and keeps an Equal Weight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY:
- Incyte price target raised to $120 from $119 at Stifel
- Incyte: Long-Term Revenue Durability and Underappreciated Pipeline Support Buy Rating and $135 Target
- Incyte Earnings Call Highlights Growth Beyond Jakafi
- Morning Movers: Fiserv and Spotify jump following fourth quarter results
- Incyte sees FY26 product revenue $4.77B-$4.94B